stella
beta
Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma — Stella
Recruiting
Back to Neoplasms trials
Trial locations
(1 site)
China
Jinling Hospital, Nanjing, Jiangsu
View full record on ClinicalTrials.gov